A Darwinian perspective on tumor immune evasion.
Breast cancer
Immune evasion
Tumor evolution
Journal
Biochimica et biophysica acta. Reviews on cancer
ISSN: 1879-2561
Titre abrégé: Biochim Biophys Acta Rev Cancer
Pays: Netherlands
ID NLM: 9806362
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
received:
17
06
2021
revised:
21
11
2021
accepted:
14
12
2021
pubmed:
22
12
2021
medline:
26
4
2022
entrez:
21
12
2021
Statut:
ppublish
Résumé
Evading immune-mediated destruction is a critical step of tumor evolution and the immune system is one of the strongest selective pressures during tumorigenesis. Analyzing tumor immune evasion from a Darwinian perspective may provide critical insight into the mechanisms of primary immune escape and acquired resistance to immunotherapy. Here, we review the steps required to mount an anti-tumor immune response, describe how each of these steps is disrupted during tumorigenesis, list therapeutic strategies to restore anti-tumor immunity, and discuss each mechanism of immune and therapeutic evasion from a Darwinian perspective.
Identifiants
pubmed: 34933050
pii: S0304-419X(21)00169-4
doi: 10.1016/j.bbcan.2021.188671
pmc: PMC8818030
mid: NIHMS1766760
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
188671Subventions
Organisme : NCI NIH HHS
ID : R35 CA197623
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Références
Curr Opin Immunol. 2017 Apr;45:43-51
pubmed: 28192720
Cancers (Basel). 2021 Sep 03;13(17):
pubmed: 34503256
Cell. 2017 Feb 9;168(4):707-723
pubmed: 28187290
Cancer Immunol Res. 2019 Jul;7(7):1148-1161
pubmed: 31088845
Nat Immunol. 2018 Jun;19(6):538-546
pubmed: 29777219
Cancer Discov. 2016 Dec;6(12):1382-1399
pubmed: 27663893
Eur J Immunol. 2019 Aug;49(8):1140-1146
pubmed: 31257581
Immunity. 2011 Aug 26;35(2):161-8
pubmed: 21867926
Cancer Res. 2010 Nov 1;70(21):8368-77
pubmed: 20940398
Cell. 2019 Mar 7;176(6):1248-1264
pubmed: 30849371
Cell. 2017 Nov 30;171(6):1259-1271.e11
pubmed: 29107330
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20422-7
pubmed: 19088187
Trends Cancer. 2017 Nov;3(11):797-808
pubmed: 29120755
Nature. 2019 Jul;571(7766):570-575
pubmed: 31243362
Nature. 2014 Oct 2;514(7520):54-8
pubmed: 25079331
Oncoimmunology. 2018 Mar 26;7(7):e1445453
pubmed: 29900056
Nat Immunol. 2019 Sep;20(9):1100-1109
pubmed: 31358997
Immunotherapy. 2011 Oct;3(10):1223-33
pubmed: 21995573
Immunol Cell Biol. 2005 Oct;83(5):451-61
pubmed: 16174093
Nature. 2004 Jan 8;427(6970):154-9
pubmed: 14712275
Nat Immunol. 2002 Nov;3(11):991-8
pubmed: 12407406
N Engl J Med. 2017 Jun 1;376(22):2109-2121
pubmed: 28445112
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Cancer J. 2017 Jul/Aug;23(4):201-205
pubmed: 28731941
Immunol Rev. 2010 Nov;238(1):12-22
pubmed: 20969581
Cancer Res. 2003 Oct 15;63(20):6784-90
pubmed: 14583474
J Clin Oncol. 2015 Jun 10;33(17):1889-94
pubmed: 25667295
Immunol Cell Biol. 2015 Mar;93(3):290-6
pubmed: 25367186
Nature. 2012 Oct 18;490(7420):412-6
pubmed: 23051752
Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10746-51
pubmed: 19520829
Cell. 2017 Sep 7;170(6):1120-1133.e17
pubmed: 28803728
Sci Transl Med. 2015 Jan 7;7(269):269rv1
pubmed: 25568072
Immunology. 2019 Jul;157(3):187-189
pubmed: 31225653
Physiol Rev. 2011 Jul;91(3):1071-121
pubmed: 21742796
Nat Rev Immunol. 2018 Dec;18(12):773-789
pubmed: 30254251
Nat Genet. 2016 Mar;48(3):238-244
pubmed: 26780609
Nat Rev Cancer. 2018 May;18(5):313-322
pubmed: 29449659
Nat Commun. 2018 Jan 2;9(1):32
pubmed: 29296022
Am J Clin Oncol. 2016 Feb;39(1):98-106
pubmed: 26558876
Trends Cancer. 2017 Jan;3(1):56-71
pubmed: 28718426
Nat Commun. 2017 Oct 6;8(1):793
pubmed: 28986561
Cell. 2015 Jan 15;160(1-2):48-61
pubmed: 25594174
Curr Opin Immunol. 2017 Aug;47:85-92
pubmed: 28755541
Trends Genet. 2009 Jan;25(1):30-8
pubmed: 19054589
Ann Oncol. 2016 Aug;27(8):1492-504
pubmed: 27207108
N Engl J Med. 2012 Mar 8;366(10):883-892
pubmed: 22397650
Clin Ther. 2015 Apr 1;37(4):764-82
pubmed: 25823918
Front Immunol. 2021 Jul 20;12:715234
pubmed: 34354714
Cell Res. 2017 Jan;27(1):74-95
pubmed: 28025976
Nature. 2012 Feb 08;482(7385):405-9
pubmed: 22318517
Nat Rev Clin Oncol. 2019 Mar;16(3):151-167
pubmed: 30523282
Lancet Oncol. 2017 Dec;18(12):e731-e741
pubmed: 29208439
Proc Biol Sci. 2015 Dec 22;282(1821):20143085
pubmed: 26702035
Nat Rev Immunol. 2013 May;13(5):309-20
pubmed: 23598650
Cancer Res. 2010 Aug 1;70(15):6171-80
pubmed: 20631075
Cancer Res. 2013 Jan 15;73(2):617-28
pubmed: 23188505
Curr Opin Immunol. 2015 Jun;34:22-7
pubmed: 25597442
Nat Rev Genet. 2019 Jul;20(7):404-416
pubmed: 30918367
Cancer Cell. 2014 Nov 10;26(5):605-22
pubmed: 25517747
Cancer Immunol Res. 2020 Feb;8(2):192-202
pubmed: 31831634
Mol Cell. 2019 Nov 7;76(3):359-370
pubmed: 31668929
FEBS J. 2016 Jul;283(14):2731-48
pubmed: 26787424
Nat Med. 2018 Dec;24(12):1845-1851
pubmed: 30397353
Nat Rev Immunol. 2009 May;9(5):353-63
pubmed: 19365408
Front Oncol. 2021 Jan 11;10:614230
pubmed: 33505920
Semin Immunopathol. 2019 Jan;41(1):49-58
pubmed: 30187086
Clin Dev Immunol. 2012;2012:925135
pubmed: 22474485
Curr Opin Immunol. 2014 Apr;27:16-25
pubmed: 24531241
Annu Rev Med. 2019 Jan 27;70:437-450
pubmed: 30379598
Immun Ageing. 2008 Sep 24;5:11
pubmed: 18816370
Immunol Rev. 2016 May;271(1):200-20
pubmed: 27088916
Curr Opin Immunol. 2016 Apr;39:44-51
pubmed: 26796069
Biophys J. 2020 Feb 4;118(3):565-577
pubmed: 31928762
Cancer Immunol Res. 2020 Jan;8(1):146-154
pubmed: 31719056
Blood. 2008 Apr 1;111(7):3635-43
pubmed: 18223165
J Immunol. 2010 Dec 15;185(12):7452-9
pubmed: 21057081
J Clin Pathol. 2018 Mar;71(3):189-194
pubmed: 29097600
Trends Immunol. 2017 Jun;38(6):432-443
pubmed: 28499492
Front Pharmacol. 2017 Aug 23;8:561
pubmed: 28878676
Immunity. 2004 Aug;21(2):137-48
pubmed: 15308095
Immunology. 2019 May;157(1):3-12
pubmed: 30897205
Annu Rev Med. 2017 Jan 14;68:139-152
pubmed: 27860544
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Immunity. 2016 Mar 15;44(3):698-711
pubmed: 26982367
Int Rev Cell Mol Biol. 2019;349:55-151
pubmed: 31759434
Nature. 2015 Feb 19;518(7539):422-6
pubmed: 25470049
N Engl J Med. 2012 Mar 8;366(10):925-31
pubmed: 22397654
Sci Transl Med. 2012 Mar 28;4(127):127ps8
pubmed: 22461638
Nat Rev Immunol. 2004 Jan;4(1):67-72
pubmed: 14704769
Trends Cell Biol. 2017 Apr;27(4):241-254
pubmed: 27986534
Immunol Cell Biol. 2016 Mar;94(3):236-41
pubmed: 26700072
Front Immunol. 2019 Feb 08;10:168
pubmed: 30800125
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Nat Rev Cancer. 2019 Aug;19(8):465-478
pubmed: 31278396
Clin Cancer Res. 2015 Nov 15;21(22):5047-56
pubmed: 26567364
World J Gastroenterol. 2018 Dec 28;24(48):5418-5432
pubmed: 30622371
Nat Rev Drug Discov. 2015 Aug;14(8):561-84
pubmed: 26228759
Cancer Res. 2005 Nov 15;65(22):10139-44
pubmed: 16287995
Oncogene. 2016 Nov 17;35(46):5931-5941
pubmed: 27086930
Front Cell Dev Biol. 2020 Feb 11;8:17
pubmed: 32117960
Biochim Biophys Acta. 2016 Apr;1865(2):168-75
pubmed: 26868867
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
Cancer Cell. 2017 Mar 13;31(3):311-325
pubmed: 28292435
Oncotarget. 2017 Nov 25;8(66):110693-110707
pubmed: 29299180
Cancer Lett. 2018 Apr 10;419:210-221
pubmed: 29414305
Trends Cell Biol. 2019 Jul;29(7):569-579
pubmed: 30987806
Nat Rev Immunol. 2018 Aug;18(8):498-513
pubmed: 29743717
Cancer Res. 2005 Feb 1;65(3):1089-96
pubmed: 15705911
Immunity. 2018 Feb 20;48(2):202-213
pubmed: 29466753
EMBO J. 2021 Sep 15;40(18):e108389
pubmed: 34459009
Trends Cancer. 2016 May;2(5):263-276
pubmed: 28741512
Immunity. 2014 Nov 20;41(5):694-707
pubmed: 25517612
Cell Immunol. 2019 Sep;343:103753
pubmed: 29395859
Nat Rev Cancer. 2019 Mar;19(3):133-150
pubmed: 30755690
Immunity. 2019 Apr 16;50(4):871-891
pubmed: 30995504
N Engl J Med. 2016 Sep 1;375(9):819-29
pubmed: 27433843
Ann N Y Acad Sci. 2018 Apr;1417(1):104-115
pubmed: 29566262
Nature. 2019 Mar;567(7749):479-485
pubmed: 30894752
Mol Cancer. 2019 Aug 23;18(1):128
pubmed: 31443694
N Engl J Med. 2013 Jul 11;369(2):134-44
pubmed: 23724846
Nat Med. 2019 Oct;25(10):1488-1499
pubmed: 31591590
J Virol. 2005 Mar;79(6):3675-83
pubmed: 15731261
J Hematol Oncol. 2019 Sep 6;12(1):93
pubmed: 31492199
Semin Immunopathol. 2019 May;41(3):327-337
pubmed: 30989321
Nat Commun. 2016 Aug 30;7:12624
pubmed: 27571927
Nature. 2012 Jan 18;481(7381):306-13
pubmed: 22258609
Science. 2015 Apr 3;348(6230):56-61
pubmed: 25838373
Mol Oncol. 2014 Sep 12;8(6):1132-9
pubmed: 25106088
Cancer Res. 2014 Dec 15;74(24):7168-74
pubmed: 25477332